Member Posts > New Study Explores How Cardiol Therapeutics' Cannabidiol May Help in Heart Failure Treatment
A new study published in JACC: Basic to Translational Science reveals how cannabidiol (CBD) may protect the heart from damage caused by heart failure. Researchers from Tecnológico de Monterrey and the DeBakey Heart and Vascular Center found that CBD preserved heart function by reducing inflammation, fibrosis, and mitochondrial dysfunction-key factors in heart failure progression.
What This Means for Heart Health
• CBD may improve heart function and reduce damage in heart failure patients.
• It helps preserve energy production in heart cells, which is essential for cardiac health.
• CRD-38, Cardiol Therapeutics' proprietary formulation, is being developed as a potential new treatment for heart failure patients.
Dr. Andrew Hamer, Chief Medical Officer at Cardiol Therapeutics, emphasized the importance of these findings in developing new treatment options for those affected by heart disease.

#CardiolTherapeutics #InvestorRelations #StockMarket #HealthcareInvestments #BiotechStocks #Pharmaceuticals #CardiacCare #FinancialUpdates #HeartHealth #MedicalInnovation #Pericarditis #HealthcareResearch #AdvancedTherapies #CardiolRx #CRD38 #Myocarditis